Navigation Links
Naglazyme Approved by Brazil's National Health Surveillance Agency
Date:2/3/2009

rity of individuals with MPS VI die from disease-related complications between childhood and early adulthood. Additional information can be found at www.mpsvi.com.

About Naglazyme

Naglazyme is the first and only enzyme replacement therapy indicated for the treatment of MPS VI. Naglazyme is indicated for patients with MPS VI. Naglazyme has been shown to improve walking and stair-climbing capacity.

The most common adverse events observed in clinical trials in Naglazyme-treated patients were headache, fever, arthralgia, vomiting, upper respiratory infections, abdominal pain, diarrhea, ear pain, cough, and otitis media. Severe reactions included angioneurotic edema, hypotension, dyspnea, bronchospasm, respiratory distress, apnea, and urticaria. The most common symptoms of infusion reactions included fever, chills/rigors, headache, rash, and mild to moderate urticaria. Nausea, vomiting, elevated blood pressure, retrosternal pain, abdominal pain, malaise, and joint pain were also reported. No patients discontinued for adverse events and all patients who completed the double-blind portion of the trial continued to receive weekly infusions of Naglazyme. Nearly all patients developed antibodies as a result of treatment, but the level of the immune response did not correlate with the severity of adverse events. Because antihistamine use may increase the risk of apneic episodes, evaluation of airway patency should be considered prior to the initiation of treatment. Consideration to delay Naglazyme infusion should be given when treating patients who present with an acute febrile or respiratory illness. Additional information can be found at www.naglazyme.com.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical co
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Naglazyme Approved by Japanese Ministry of Health
2. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
3. Watsons GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
4. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
5. First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
6. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
7. Pharmaxis Aridol Approved for Sale in Switzerland
8. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
9. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
10. ARIUS sale approved by shareholders
11. Video: Keppra XR(TM) Approved in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... -- Intarcia Therapeutics, Inc. today announced the ... the cost and predictability of non-adherence in type 2 ... of the European Association for the Study of Diabetes ... , Ph.D., of Analysis Group, Inc. presented data from ... studies to characterize the prevalence of non-adherence and serial ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced that it has been ... and Trademark Office on its unique delivery system ... ) to phagocytic cells for the treatment of ...
(Date:9/17/2014)... NASA’s MESSENGER has just celebrated its 10 year anniversary ... one of its latch valves, V27200-818, operating onboard this ... of the planet Mercury. It is only the second ... a vast amount of information and images of the ... solenoids that also include permanent magnets to maintain the ...
(Date:9/16/2014)... that can harvest energy from jaw movements has been ... It is hoped that the device can generate electricity ... of small-scale implantable or wearable electronic devices, such as ... devices. , The first results of the device,s performance ... journal Smart Materials and Structures . , Jaw ...
Breaking Biology Technology:Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4'Smart material' chin strap harvests energy from chewing 2
... made the honor roll of a national economic development assessment ... , ,The 2006 Development Report Card for the States, released ... the state an A in performance and Bs in business ... there were a few stinkers hidden in the subcategories that ...
... Lori Holder-Webb , an assistant professor of accounting and ... Business, is part of a four-person research team recently ... NASD Investor Education Foundation recently awarded more ... both of the School of Management of Boston College, ...
... Visonex will receive $109,000 in loans ... office said. The company provides web-based disease management software for ... to hire nine people as part of its current growth ... money includes: , , $100,000 loan from the Technology ...
Cached Biology Technology:
(Date:9/16/2014)... (September 17, 2014)The North American Menopause Society (NAMS) ... comprehensive care of midlife womenon everything from hot ... North American Menopause Society Recommendations for Clinical Care ... the Society,s journal Menopause . This is ... the care of midlife women freely available to ...
(Date:9/16/2014)... discovered the "molecular brakes" that time the generation of ... These "hair cells" translate sound waves into electrical signals ... as sounds. If the arrangement of the cells is ... the research will be published in The Journal ... Hey1 and Hey2 act as brakes to prevent hair ...
(Date:9/16/2014)... we inherit certain traits from our parents that are ... genes play out by taking certain drugs or better ... a team of researchers at the Boston University School ... epigenetics research. , Epigenetics regulates gene expression in ... proteins, which prevent permanent mutations or alterations within the ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3
... of life imitating art, avian scents given off by male ... Michigan State University researcher revealed the process of how males ... issue of Behavioral Ecology . Scents are used in ... evaluating mates. But this is the first study of its ...
... dopamine is best known for its roles in the ... reward, learning and memory. Now, Vanderbilt University Medical Center ... in the kidneys is important for renal ... published in the July Journal of Clinical Investigation ...
... July 19, 2011 -- How is it that a disc-like ... into an elongated embryo? This mechanism is a mystery ... The first significant step towards understanding the issue was made ... embryologists Hans Spemann and Hilde Mangold. The two used early ...
Cached Biology News:Avian 'Axe effect' attracts attention of females and males 2Kidney dopamine regulates blood pressure, life span 2Hebrew U. scientists show for first time how early human embryo acquires its shape 2
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
Mouse monoclonal antibody raised against a partial recombinant SCARB2. NCBI Entrez Gene ID = SCARB2...
...
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048...
Biology Products: